PofoliaShared via Pofolia

International Journal of Molecular Sciences· 2026Q1

Maternal Endocrine and Vascular Perturbations Reprogram the Transcriptomic and Secretory Profile of Perinatal Stem Cells: A Comparative Study of Umbilical Cord-Derived Stem Cell UC-MSCs and Human Milk-Derived Stem Cell MM-MSCs

Dominika Przywara, Wiktor Babiuch, Pola Kosteczko, Alicja Petniak et al.

Short summary

Maternal hypertension reprogrammed umbilical cord stem cells (UC-MSCs) towards a profibrotic signature, suppressing cell migration genes and reducing FGFR1 expression, while maternal hypothyroidism suggested a rescue response in UC-MSCs but a paracrine deficit in milk.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Maternal hypertension associated with profibrotic signature and suppressed cell migration in UC-MSCs.
  • Maternal hypertension linked to reduced FGFR1 expression in UC-MSCs.
  • Maternal hypothyroidism showed contrasting effects: rescue response in UC-MSCs vs. paracrine deficit in milk.
  • History of miscarriage altered MM-MSC mechanisms, while stillbirths increased milk IGF-1 threefold.

AI-generated from the title and abstract; the full text is not read.

Abstract

Perinatal mesenchymal stem cells (MSCs) are characterized by high phenotypic plasticity, allowing them to dynamically adapt to microenvironmental stimuli. However, the extent to which maternal pathophysiology and clinical history in vivo permanently alter their biological properties remains poorly understood. The aim of this study is to determine the influence of the maternal in vivo environment—including vascular stress (gestational hypertension), metabolic stress (hypothyroidism), and obstetric history (miscarriages, stillbirths)—on the transcriptomic, proteomic, and epigenetic profiles of growth factors in umbilical cord blood stem cells (UC-MSCs) and human milk stem cells (MM-MSCs). UC-MSCs (n = 51) and MM-MSCs (n = 78) were isolated from eligible donors. Global transcriptomic pathways associated with maternal hypertension were examined in UC-MSCs using Affymetrix expression microarrays. Targeted polymerase chain reaction (qPCR) validation was performed in both cell sources for key growth factors and receptors and for microRNA-155 in MM-MSCs. Paracrine protein concentrations (HGF, IGF-1, VEGF) in whole milk were quantified using ELISA. Microarray screening demonstrated that maternal hypertension is associated with a transcriptomic shift in the UC-MSCs towards a profibrotic signature, marked by an increased expression of the canonical Wnt signaling pathway and structural components of the extracellular matrix, while simultaneously suppressing the expression of genes associated with cell migration networks. qPCR confirmed that maternal hypertension is associated with significantly reduced FGFR1 expression and a downward trend in EGF and HGF in UC-MSCs, while correlating with an asymmetric response in MM-MSCs. Maternal hypothyroidism was linked to a transcriptomic profile suggestive of a rescue response (a trend toward increased IGF1 and EGF expression) in UC-MSCs, in contrast to a potential paracrine translation deficit (trends toward reduced VEGF, HGF, and IGF-1 protein levels) in the milk matrix. Importantly, a history of miscarriage correlated with alterations in the cellular mechanism of MM-MSCs (a trend toward increased IGF1 and EGF mRNA expression), while previous stillbirths were associated with a systemic, threefold increase in free IGF-1 protein concentration in whole milk. This paracrine dynamic strongly correlated with miR-155 expression, suggesting a potential regulatory role in the lactation niche. Our findings suggest that the molecular and epigenetic makeup of perinatal stem cell niches is dynamically and persistently associated with the mother’s somatic health and reproductive history. This tissue-specific plasticity provides robust molecular support for the DOHaD paradigm, indicating that offspring stem cell profiles may directly reflect the maternal inheritance in vivo.

The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Genetics (Medicine)

GeneticsMedicine